NCT01960725 An Alternate Dosing Schedule for Pentavalent Rotavirus Vaccine (RotaTeq) Status COMPLETED Phase PHASE4
NCT01958671 A Study of the Efficacy and Safety of Ertugliflozin Monotherapy in the Treatment of Participants With Type 2 Diabetes Mellitus and Inadequate Glycemic Control Despite Diet and Exercise (MK-8835-003, VERTIS MONO) Status COMPLETED Phase PHASE3
NCT01953692 A Trial of Pembrolizumab (MK-3475) in Participants With Blood Cancers (MK-3475-013/KEYNOTE-013) Status COMPLETED Phase PHASE1
NCT01953601 Efficacy and Safety Trial of Verubecestat (MK-8931) in Participants With Prodromal Alzheimer's Disease (MK-8931-019) Status TERMINATED Phase PHASE3
NCT01951339 Impact of Sitagliptin on Cardiovascular Exercise Performance in Type 2 Diabetes Status COMPLETED Phase NA
NCT01949168 A Pilot Study of Boceprevir for the Treatment of Genotype 6 HCV Status UNKNOWN Phase PHASE2
NCT01949077 Evaluation of Serum Chemokines for Patients Undergoing Treatment With Boceprevir. Status WITHDRAWN Phase N/A
NCT01948986 Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Participants With Type 2 Diabetes Mellitus (MK-8835-009) Status COMPLETED Phase PHASE1
NCT01945931 Evaluation of a Smartphone Application to Reduce Adverse Pregnancy Outcomes in Ethiopia Status COMPLETED Phase NA
NCT01945294 Short Duration Versus Standard Response-Guided Therapy With Boceprevir Combined With PegIntron and Ribavirin in Previously Untreated Non-Cirrhotic Asian Participants With Chronic HCV Genotype 1 (MK-3034-107) Status COMPLETED Phase PHASE3
NCT01945281 Safety, Tolerability, and Efficacy of Caspofungin Versus Amphotericin B Deoxycholate in the Treatment of Invasive Candidiasis in Neonates and Infants (MK-0991-064) Status TERMINATED Phase PHASE2
NCT01943422 Safety and Efficacy Study of Vemurafenib and High-dose Interferon Alfa-2b in Melanoma Status COMPLETED Phase PHASE1
NCT01937975 The Pharmacokinetics of Grazoprevir (MK-5172) and Elbasvir (MK-8742) in Participants With Renal Insufficiency (MK-5172-050) Status COMPLETED Phase PHASE1
NCT01936376 A Prospective Observational Study to Evaluate Acute Kidney Injury Biomarkers In Patients Receiving First Cycle of Cisplatin Chemotherapy for Head and Neck Cancers Status UNKNOWN Phase N/A